These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
503 related items for PubMed ID: 22612858
1. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District. Kubio C, Tierney G, Quaye T, Nabilisi JW, Ziemah C, Zagbeeb SM, Shaw S, Murphy WG. Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858 [Abstract] [Full Text] [Related]
2. Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution. Hussein E, Teruya J. Transfusion; 2012 Nov; 52(11):2321-8. PubMed ID: 23163293 [Abstract] [Full Text] [Related]
3. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience. Vučetić D, Kecman G, Ilić V, Balint B. Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495 [Abstract] [Full Text] [Related]
4. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebié YK, Kiba A, Dahourou H, Ouattara S, Nikiema JB, Moret R, Zongo JD, Simpore J. Trop Med Int Health; 2012 Feb; 17(2):247-53. PubMed ID: 21988100 [Abstract] [Full Text] [Related]
5. [Seroprevalence of markers of transfusion transmissible infections in blood bank in Colombia]. Bedoya JA, Cortés Márquez MM, Cardona Arias JA. Rev Saude Publica; 2012 Dec; 46(6):950-9. PubMed ID: 23503536 [Abstract] [Full Text] [Related]
6. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group. Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [Abstract] [Full Text] [Related]
7. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia. Ben Jemia R, Gouider E. Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983 [Abstract] [Full Text] [Related]
8. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ. Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [Abstract] [Full Text] [Related]
9. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE. Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604 [Abstract] [Full Text] [Related]
10. Evaluation of blood donors questionnaire in a developing country: The case of Gabon. Kouegnigan Rerambiah L, Biyoghe AS, Bengone C, Djoba Siawaya JF. Transfus Clin Biol; 2014 Jun; 21(3):116-9. PubMed ID: 24811564 [Abstract] [Full Text] [Related]
11. Relative safety of first-time volunteer and replacement donors in West Africa. Allain JP, Sarkodie F, Asenso-Mensah K, Owusu-Ofori S. Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284 [Abstract] [Full Text] [Related]
12. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM. Hum Antibodies; 2011 Feb; 20(3-4):77-82. PubMed ID: 22129677 [Abstract] [Full Text] [Related]
13. Seroprevalence of transfusion transmissible infections among blood donors at the blood bank of a Medical College of Kolkata. Karmakar PR, Shrivastava P, Ray TG. Indian J Public Health; 2014 Feb; 58(1):61-4. PubMed ID: 24748361 [Abstract] [Full Text] [Related]
14. AIDS and blood transfusions: ensuring safe blood supplies. Finger WR. Netw Res Triangle Park N C; 1990 Apr; 11(2):5-7,20. PubMed ID: 12342809 [Abstract] [Full Text] [Related]
15. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. Lackritz EM. AIDS; 1998 Apr; 12 Suppl A():S81-6. PubMed ID: 9632988 [Abstract] [Full Text] [Related]
16. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779 [Abstract] [Full Text] [Related]
17. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM. Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [Abstract] [Full Text] [Related]
18. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Sultan F, Mehmood T, Mahmood MT. Int J Infect Dis; 2007 Sep; 11(5):407-12. PubMed ID: 17331775 [Abstract] [Full Text] [Related]
19. [Infectious markers among blood donors in Democratic Republic of Congo (DRC)]. Batina A, Kabemba S, Malengela R. Rev Med Brux; 2007 Sep; 28(3):145-9. PubMed ID: 17708468 [Abstract] [Full Text] [Related]
20. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. van Hulst M, Hubben GA, Sagoe KW, Promwong C, Permpikul P, Fongsatitkul L, Glynn DM, Sibinga CT, Postma MJ. Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093 [Abstract] [Full Text] [Related] Page: [Next] [New Search]